{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02377",
      "entity_text" : "VTE",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:22833565",
      "entity_text" : "Dalteparin",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Dalteparin reduced the rate of VTE to 2.8% without increasing the major hemorrhage rate, compared to the placebo group, with an incidence of 4.9%.",
  "reading_complete" : "2020-08-04T14:00:44Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T13:58:59Z",
  "trigger" : "reduced",
  "evidence" : [ "Dalteparin reduced the rate of VTE" ],
  "pmc_id" : "6542320",
  "score" : 0
}